Purdue Pharma L.p.

Emisphere Technologies, Inc.

Euro-celtique S.a.

Ihor Shevchuk

Benjamin Oshlack

Curtis Wright

Richard S Sackler

Steven Minh Dinh

Bruce Reidenberg

Puchun Liu

Anthony E Carpanzano

Kirti H Valia

Mark Alfonso

Richard Maskiewicz

Lino Tavares

Geraldine Marcenyac

Mohammed Shameem

Kevin Long

Bruce E Reidenberg

James P Cassidy

Carl J Baker

Mark A Alfonso

Rampurna Prasad Gullapalli

The present invention relate to pharmaceutical formulations that include a CPHPC component and a delivery agent compound.

Pharmaceutical formulations for the treatment of alzheimer's disease

A tansdermal delivery device for effectively treating seasonal allergic rhinitis and chronic idiopathic urticariain in humans is disclosed and methods thereof.

Loratadine transdermal device and methods

The present invention provides a topical composition comprising (a) at least one delivery agent compound and (b) a acyclovir compound. Methods of treatment, and methods of preparing the topical composition are also provided.

Topical administration of acyclovir

A method of effectively treating benign prostatic hypertension in humans is achieved by administering amorphous terazosin via a transdermal formulation. Preferably, the transdermal formulation is applied to the skin of the patient and maintained in contact with the skin for at least about 24 hours, and preferably for about 3 to about 8 days.

Terazosin transdermal device and methods

A method of effectively treating hypertension in humans is achieved by administering felodipine via a transdermal formulation. Preferably, the transdermal formulation is applied to the skin of the patient and maintained in contact with the skin for at least about 24 hours days, and preferably for about 3 to about 8 days.

Felodipine transdermal device and methods

Growing community of inventors

Yonkers, NY, United States of America

Ihor Shevchuk